Galenica profit up 50% in first half of 2008

Swiss diversified pharmaceutical group Galenica has rebounded from accusations it witheld information from investors to increase its earnings by over 50% during the first six months of 2008.

The firm reported revenue up 8.3% to 1.34 billion Swiss francs ($1.22 billion), versus the same period of last year. This contributed to net profit increasing 52.1% to 105.1 million francs. As such, the company predicts its consolidated earnings will grow 40% during the full-year period of 2008.

Pharmaceutical sales up 7.6%